WS12-3 Real-world outcomes among patients with cystic fibrosis treated with lumacaftor/ivacaftor (LUM/IVA) in 2017: an interim analysis of data from the US CF Foundation Patient Registry (CFFPR)
Year: 2019
Type: article
Study design: Observational Study
Source: Journal of Cystic Fibrosis
Authors: C. Knox, Z. Han, R. Wu, L.T. Wang, A. Elbert, S. Tian
Institution: Newcastle upon Tyne Hospitals NHS Foundation Trust
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2947581345
